John Dirk Vestergaard Nieland
John Dirk Vestergaard Nieland, Associate Professor and PhD, is Head of the Molecular Pharmacology Research Group at Aalborg University in Denmark. He was born in The Netherlands and has been working at the Netherlands Cancer Institute and Loyola University in the USA on cancer and viral vaccines.
He has a long-time experience in academic and biotech research, medicinal development, and platform development in a broad range of topics. His primary research focuses on the development and progression of neurodegenerative diseases in relation to metabolic imbalances.
Besides academic research, he is co-founder of 2N Pharma, which is a small biotech company developing medicine for the treatment of Amyotrophic Lateral Sclerosis (ALS) and Parkinson´s Disease.